Thieler Law Corp advises investors with losses exceeding $100,000 of the May 16, 2017 lead plaintiff deadline in a class action lawsuit filed against Insys Therapeutics Inc (NASDAQ:INSY) (“Insys” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased Insys Therapeutics Inc securities between February 23, 2016 and March 15, 2017, have until May 16, 2017 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Insys Therapeutics Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that INSYS had overstated its 2015 net revenue; INSYS had misstated its sales allowances for 2016; accordingly, the Company lacked effective internal controls over financial reporting; and as a result, INSYS public statements were materially false and misleading at all relevant times.

On March 15, 2017, Insys revealed that it would postpone filing its financial results for the quarter and year ended December 31, 2016. The Company stated “[t]he Audit Committee of the Company’s Board of Directors has been conducting an independent review of the Company’s processes related to estimation of, and increases to, certain sales allowances recorded during 2016, with a potential reduction of 2015 net revenue and pre-tax income not expected to exceed $5 million, as well as extended payment terms offered to certain customers during the third quarter of 2016.”

Following this news, NASDAQ:INSY dropped $0.49 per share or roughly 5% to close at $10.06 per share on March 16, 2017.

If you were negatively impacted by your investment in Insys Therapeutics Inc securities between February 23, 2016 and March 15, 2017 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185